| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |